Friday, December 10, 2021

17,000+ Doctors and Scientists Unite to WARN the public about the Hidden Dangers of COVID Vaccines

"WE ARE NOT ONE DOCTOR, WE ARE 17,000 DOCTORS" SPEECH AT STOP THE MANDATES RALLY DC





In this video below, Dr. Robert Malone (co-founder of MRNA vaccines) cites a website where you can find over 16,000 doctors and scientists who have united to tell the truth about the corruption behind the Covid pandemic. 


You can see many more videos with Dr. Malone, by CLICKING HERE.
You can see how these Vaccines violate the Nuremberg code, by CLICKING HERE.
You can see how the CDC withheld information about the side effects by CLICKING HERE.
You can see how the FDA withheld information about the side effects by CLICKING HERE.
You can see how Pfizer withheld information about the side effects by CLICKING HERE and HERE.
 

Look at all the doctors and scientists who tuned in for this call (hosted by Ron Desantis) about the corruption that's been going on, during the Covid pandemic! You can watch this video conference call by CLICKING HERE.




There's Something Much Bigger Going On Here | Dr. Robert Malone 2022





THIS VIDEO IS A MUST-SEE! hundreds of doctors, nurses, scientists, virologists, epidemiologists and more, telling the truth about COVID-19 (and how to beat it)


The Highwire has featured hundreds of doctors, scientists, and virologists, who've told the TRUTH about the COVID Pandemic, on their show. You can see them in this eye-opening video montage, below. If you're not already familiar with the Highwire - it is an excellent place to see videos by REAL EXPERTS on COVID (interviews you will NEVER see in the Mainstream Media).  

If you're not already aware of how the mainstream media (heavily funded by Bill Gates) manipulates their stories and misleads the public in order to keep the money flowing in... CLICK HERE.

To go to the Highwire's page, where you can see hundreds of informative videos, CLICK HERE.

You can also learn about The Highwire's Founder, Del Bigtree, and the Nonprofit he created (ICAN) to educate the public about Vaccine Safety, by clicking HERE.  You can see a page of ICAN's fact checks, by clicking HERE.



Please be sure to scroll down and look at all the doctors who've joined   Doctors4CovidEthics.ORG...  

Dr. Peter McCullough has a VERY eye-opening with Joe Rogan, in which he talks about how hard he worked to figure out ways to treat COVID patients early, prophylactically, so they wouldn't have to be hospitalized. But as he could see, the patients were being treated in a way that protected the doctors and hospitals, more than the patients.

Dr. McCullough's credentials:

Over 650 Publications in the National Library of Medicine 

Internist, Cardiologist, trained in Epidemiology, Editor of a major journal in Cardiovascular Medicine, President of a Major Medical Society, the Most published person in his field (heart and kidney disease) in history.

Despite all his credentials, Dr. McCullough has been heavily censored by YouTube, for going against the chosen narrative by the CDC. He is one of literally HUNDREDS of doctors who have tried to speak out about the dangers of the COVID vaccines, to protect public health.

THE FULL INTERVIEW BETWEEN JOE ROGAN AND DR. PETER MCCULLOUGH


DR. PETER MCCULLOUGH - URGENT WARNING ABOUT POISONOUS JABS - "AN AGONIZING SITUATION"

 

Since the beginning of the COVID Pandemic, honest and ethical scientists like Dr. Michael Yeadon have been trying to warn people about the untold dangers of these MRNA vaccines. Dr. Yeadon is a 16-year veteran and VP from Pfizer, who left on good terms, to start his own company.  He's always had a good relationship with Pfizer, but he couldn't ignore the glaring risks of these untested MRNA vaccines, because he knew they were severely lacking in safety testing, and they were likely to cause heart attacks. He knew of 3 papers that showed: when spike proteins were injected into animals, in vaccine trials for previous SARS viruses.... it caused blood clots. Sadly, his worst nightmares have come true, and that is exactly what is happening now

Dr. Yeadon's pleas to the public were censored and ignored. So many people are quick to blow off award-winning doctors and scientists (many of whom are successfully treating patients with safe and effective methods), while putting their trust in appointed bureaucrats like Tony Fauci and questionable leaders of the W.H.O..  Keep in mind that the people pushing vaccines the hardest are not doctors who are actually treating any patients. Many of these people have a long history of lying to the public, and they also stand to make a fortune from vaccines.

Caring doctors like Michael Yeadon have nothing to gain financially, from warning the public about vaccines  (but they have everything to lose, financially, by speaking out against highly profitable product of the pharmaceutical industry).  Some have even received death threats.

Dr. Yeadon literally contacted thousands of media outlets (by doing a press release) to warn the public and ONLY THREE outlets were willing to cover his story (Children's Health Defense, The Highwire, and a tabloid). You can see from this video - Dr. Yeadon deeply understands the science and dangers of these vaccines, whereas "doctors" like Tony Fauci, appear to ignore the most critical science, in order to further their own political and financial agendas. 

Please have a look at the videos on this page and decide for yourself who really has your best interests at heart.

Dr. Yeadon warns the public of how dangerous MRNA vaccines really can be. Again... before the vaccine rollout, he found THREE PAPERS that showed spike proteins, when injected into animals, can cause BLOOD CLOTS.

You can see Dr. Yeadon's FULL INTERVIEW on the Highwire, HERE.

Here's another interview with Dr. Yeadon:

AN URGENT WARNING TO THE WORLD ABOUT COVID19 VACCINES FROM EX PFIZER EXEC DR MIKE YEADON


see hundreds of doctors and scientists telling the truth about the covid pandemic in the last 100 episodes of the highwire! (scroll to 14:21)


DR. PETER MCCULLOUGH - 50% DEAD IN 48 HOURS - 80% DEAD IN A WEEK


Dr. Rodger Hodkinson tried to warn people as well, and his warnings were ignored. He points out how Myocarditis can appear DECADES after getting vaccinated.

DOCTORS AROUND THE WORLD ISSUE DIRE WARNING DO NOT GET THE COVID VACCINE


Some resources from this page by Meryl Nass, M.D.:

https://merylnassmd.com/how-you-can-receive-early-effective/


How you can receive early effective treatment for Covid

US Doctor groups willing to treat Covid patients with appropriate medications:

1.  Dr. Zev Zelenko’s new website. He pioneered HCQ treatments in the US:

https://www.vladimirzelenkomd.com/

2.  Dr Peter McCullough et al’s protocol–please scroll down to the gray area to click on a small spot to download the full text

https://rcm.imrpress.com/EN/10.31083/j.rcm.2020.04.264

3.  version 7 of iMASK protocol

4.  https://c19protocols.com/ (Wonderful collection of information on protocols and a list of doctors’ groups who treat patients using these protocols, includes several I am not familiar with)

Telemedicine: https://www.americasfrontlinedoctors.com/how-do-i-get-hcq/

Telemedicine: FrontlineMDs.com

Telemedicine: https://myfreedoctor.com/

List of Independent Practices: https://aapsonline.org/covidearlytreatment

List #2 Independent Practices: https://www.doctorsdontfearcovid.com/

List #3 “Directory of Doctors Prescribing Outpatient COVID-19 Therapy”: https://www.exstnc.com/

FLCCC Alliance: https://covid19criticalcare.com/network-support/the-flccc-alliance/

Arnot Health & Lake Erie College of Medicine (upstate NY): https://www.arnothealth.org/

Bethany Medical (North Carolina): https://bethanymedicalcenter.com/

Budesonide Protocol Practices: https://budesonideworks.com/providers/

For those who have found a  doctor that has prescribed HCQ but their pharmacy will not fulfill the early treatment prescription – it can be overnighted by – Ravkoo Pharmacy Phone: 863-875-5700

https://www.myravkoo.com/public/pharmacy

Jane Orient’s group Doctors for Disaster Preparedness discusses other potential OTC remedies.

DR. RODGER HODKINSON INTERVIEWED BY DEL BIGTREE / HIGHWIRE, ON MYOCARDITIS AFTER COVID JAB

Dr. Hodkisson's tried to post a warning on Twitter (below), but it was deleted, as were other tweets (and accounts) from people who tried to tell the truth about COVID.  Dr. Robert Malone, one of the founders of MRNA technology, who issued a desperate plea to parents to NOT let their kids take the MRNA vaccine, was also kicked off Twitter, for sharing this extremely informative presentation. Decide for yourself, who has your best interests at heart: These doctors who are trying to protect public health, or the Mainstream Media? 


If you REALLY want to understand the dangers of these vaccines, look at what is being said by the scientists and physicans at Doctors4CovidEthics.org.  It's a group of hundreds of real scientists around the world, who are NOT trying to profit from the success of this covid vaccination rollout. These are VERY experienced, accredited doctors and scientists with a thorough understanding of how vaccines can have a detrimental effect on the immune system. 

PLEASE have a look at their website and their posts!

https://doctors4covidethics.org/blog/

 

From their page:

We are hundreds of doctors and scientists from all corners of the globe. We have written three letters to the European Medicines Agency, urgently warning of short term and long term dangers from COVID-19 vaccines, including clotting, bleeding and platelet abnormalities. We first began warning of blood-related risks before media reports of clotting led to vaccine suspensions around the world.


‘THE BIGGEST EXPERIMENT EVER DONE’



"You are going to plant the seed of auto immune reactions."  He says. DON'T DO THIS."  

NEUROSCIENTIST’S CONCERNS ABOUT COVID VACCINES





HEALTH EXPERT: “STOP COVID VAX EXPERIMENTS”



A message from Dr. Carey Madej about adverse events from j@bs




DR. SHAWN BROOKS : THE COLD HARD TRUTH ABOUT THE VAXX





VACCINE INCREASED DEATH RATE 25 FOLD IN 10 MONTHS : DR. JAMES THORP




censored doctors, newscasters and patients speak up




WE ARE ALL PART OF A MEDICAL EXPERIMENT - BRIAN S. HOOKER .PHD


x


DR. VLADIMIR ZELENKO'S PATIENTS HAVE REGRETS ABOUT GETTING THE COVID VACCINE



PRO VAX VACCINE DEVELOPER GOES ON LINKEDIN TO TELL PROFESSIONALS TO STOP VACCINE PROGRAM




DR. RASHID A. BUTTAR



This physician talks about how these COVID vaccines wipe out your immune system.


VALUABLE INFORMATION ON THE CV VAXX




DR FLEMING ON THE SARS-COV-2 VIRUS AND VACCINES.




MEETING OF THE COVID-19 GIANTS WITH GEERT VANDEN BOSSCHE AND ROBERT MALONE MD | VEJON HEALTH




REINER FUELLMICH WITH MRNA TECHNOLOGY INVENTOR DR ROBERT MALONE 9/7/21

 


NOBEL PRIZE WINNING VIROLOGIST: CURRENT MASS VACCINATION STRATEGY AN "ENORMOUS MISTAKE"





RESPIRATORY THERAPIST FROM INDIANAPOLIS WARNS ABOUT THE VACCINE




VACCINEE AUTOPSIES: KILLER LYMPHOCYTES INVADE VITAL ORGANS, DRS SUCHARIT BHAKDI & MICHAEL PALMER

 

CV SHOTS COULD CAUSE 'CRIPPLING' NEURODEGENERATIVE DISEASE IN YOUNG PEOPLE - DR. STEPHANIE SENEFF




A message from Dr. Anne McCloskey




From the Doctors4CovidEthics site:

Doctors for Covid Ethics Signatories

Doctors for Covid Ethics has written three open letters to the European Medicines Agency regarding COVID-19 vaccine dangers. In those letters we have insisted upon evidence that risks of clotting, bleeding and platelet abnormalities were appropriately ruled out in legitimate empirical trials prior to human use. We foresaw deaths and harm from clotting, warning of these dangers before blood clots led to vaccine suspensions around the world.

The first letter, emailed February 28 and hand-delivered March 1st, can be found here. The EMA’s reply of March 23rd can be found here, and our rebuttal letter, of April 1st, here, all summarised in a press release here. Our most recent letter, warning that “cardinal symptoms of cerebral venous sinus thrombosis (CVST) dominate the list of adverse reactions to COVID-19 vaccines” is here.

Doctors, scientists and colleagues in allied disciplines related to health, ethics, law and human rights can sign the open letters by sending their name, qualifications, areas of expertise and country of practice to: Doctors4CovidEthics@protonmail.com, with web verification (eg workplace or registration link, not for publication).

Signatories across the three letters are as follows:

Founding signatories

Professor Sucharit Bhakdi MD, Professor Emeritus of Medical Microbiology and Immunology, Former Chair, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University of Mainz (Medical Doctor and Scientist) (Germany and Thailand)

Dr. Marco Chiesa MD FRCPsych, Consultant Psychiatrist and Visiting Professor, University College London (Medical Doctor) (the United Kingdom and Italy)

Dr. C Stephen Frost BSc MBChB, Specialist in Diagnostic Radiology, Stockholm, Sweden (Medical Doctor) (the United Kingdom and Sweden)

Dr. Margareta Griesz-Brisson MD PhD, Consultant Neurologist and Neurophysiologist (studied Medicine in Freiburg, Germany, specialty training for Neurology at New York University, Fellowship in Neurophysiology at Mount Sinai Medical Centre, New York City; PhD in Pharmacology with special interest in chronic low-level neurotoxicology and effects of environmental factors on brain health), Medical Director, The London Neurology and Pain Clinic (Medical Doctor and Scientist) (Germany and United Kingdom)

Professor Martin Haditsch MD PhD, Specialist (Austria) in Hygiene and Microbiology, Specialist (Germany) in Microbiology, Virology, Epidemiology/Infectious Diseases, Specialist (Austria) in Infectious Diseases and Tropical Medicine, Medical Director, TravelMedCenter, Leonding, Austria, Medical Director, Labor Hannover MVZ GmbH (Medical Doctor and Scientist) (Austria and Germany)

Professor Stefan Hockertz, Professor of Toxicology and Pharmacology, European registered Toxicologist, Specialist in Immunology and Immunotoxicology, CEO tpi consult GmbH. (Scientist) (Germany)

Dr. Lissa Johnson, BBSc (Psychology and Psychobiology) BA(Media) MPsych(Clin) PhD, Clinical Psychologist and Behavioural Scientist, Thesis in neuroimmunology, PhD in shaping reality-perception, Expertise in the social psychology of atrocity, torture, collective violence and propaganda, former professional body Public Interest Advisory Group member (Psychologist) (Australia)

Professor Ulrike Kämmerer PhD, Associate Professor of Experimental Reproductive Immunology and Tumor Biology at the Department of Obstetrics and Gynaecology, University Hospital of Würzburg, Germany, Trained molecular virologist (Diploma, PhD-Thesis) and Immunologist (Habilitation), Remains engaged in active laboratory research (Molecular Biology, Cell Biology) (Scientist) (Germany)

Associate Professor Michael Palmer MD, Department of Chemistry (studied Medicine and Medical Microbiology in Germany, has taught Biochemistry since 2001 in present university in Canada); focus on Pharmacology, metabolism, biological membranes, computer programming; experimental research focuses on bacterial toxins and antibiotics (Daptomycin); has written a textbook on Biochemical Pharmacology, University of Waterloo, Ontario, Canada (Medical Doctor and Scientist) (Canada and Germany)

Professor Karina Reiss PhD, Professor of Biochemistry, Christian Albrecht University of Kiel, Expertise in Cell Biology, Biochemistry (Scientist) (Germany)

Professor Andreas Sönnichsen MD, Professor of General Practice and Family Medicine, Department of General Practice and Family Medicine, Center of Public Health, Medical University of Vienna, Vienna (Medical Doctor) (Austria)

Dr. Wolfgang Wodarg, Specialist in Pulmonary and Bronchial Internal Medicine, Hygiene and Environmental Medicine, Epidemiology, and Public Health; Honorary Member of the Parliamentary Assembly of the Council of Europe and former Head of the Health Committee of the Parliamentary Assembly of the Council of Europe; former Member of Parliament, German Bundestag; Initiator and Spokesman for the study commission ‘Ethics and Law in Modern Medicine’; Author and University Lecturer (Medical Doctor) (Germany)

Dr. Michael Yeadon BSc (Joint Honours in Biochemistry and Toxicology) PhD (Pharmacology), Formerly Vice President & Chief Scientific Officer Allergy & Respiratory, Pfizer Global R&D; Co-founder & CEO, Ziarco Pharma Ltd.; Independent Consultant (Scientist) (United Kingdom)

Endorsing signatories

Dr Reem Abu-Sbaih, DO, Doctor of Osteopathy, Associate Professor Osteopathic Manipulative Medicine/ Neuromusculoskeletal Medicine (Medical Doctor) (USA)

Dr Adriana Reyes Agudelo, MD, Surgeon (Medical Doctor) (Spain)

Dr Véronique Ahari, General Practitioner (Medical Doctor) (France)

Dr Maria José Martínez Albarracín, Bachelor of Medicine and Surgery, Physician and Professor of Clinical Diagnostic Processes, Specialized in Clinical Analysis (Medical Doctor) (Spain)

Dr Alicja Alda, General Practitioner and Ear Nose and Throat specialist (Medical Doctor) (Norway)

Dr Fernando Ania, ND, Naturopathic Doctor (Canada)

Dr Carmen Soler Arnedo, Surgeon, General Medicine (Medical Doctor) (Spain)

Dr Lenn-Adolph D. Arre, PhD, FNIU, Former Associate Professor of Molecular Biology and Microbiology, San Beda University, Manila (Scientist) (Philippines)

Dr Mario Cabrera Avivar, MD, Specialist in Public Health, former Consultant to the Pan American Health Organisation, the World Health Organisation Regional Office for the Americas (OPS/OMS) (Medical Doctor) (Uruguay)

Rena Bartolettti, Pharmacist, previously of the General Pharmacy Inspectorate, Registration Service Medicines, Federal Public Health and Safety Authority (Pharmacist) (Belgium)

Dr Gabriela Bachmann, General Medicine, Specialising in children and young people (Medical Doctor) (Austria)

Dr. Elizabeth Bastian, BSc (Genetics and Microbiology), MDCM, Family Medicine, General Practitioner in Oncology, sub specialty trained in Palliative Care (Medical Doctor) (Canada)

Dr Pedro López Bastido, Stomatologist (Medical Doctor) (Spain)

Dr Professor Mila Aleckovic Bataille, Specialising in Psychiatry, Psychology and Anthropology (Medical Doctor and Social Scientist) (France, Serbia)

Dr Michael D Bell, MB, ChB (1978 Edinburgh) MRCGP (1989), General Practitioner (Medical Doctor) (United Kingdom)

Rev. Reuben P. Bell, DO, MS, MDiv, PhD, Osteopathic family physician since 1982, Bachelors and Masters degrees in Zoology, formerly Professor of Biology (including Molecular Genetics and Developmental Biology), M.Div. and Ph.D. in theological studies, with attention to issues of science and religion (Medical Doctor and Scientist) (USA)

Dr Francisco Lacruz Bescos, MD, PhD, Consultant Neurologist with special training and dedication to Neuroimmunology and Multiple Sclerosis (Retired) (Medical Doctor) (Spain)

Dr Thomas Binder, MD, specialised in Cardiology and Internal Medicine, thesis in Immunology and Virology, with 32 years experience in diagnosis and treatment of Acute Respiratory Illness (Medical Doctor) (Switzerland)

Sarah Binns, MA VetMB, MS, MRCVS, MSc, PhD, DipLSHTM, Former Veterinary Infectious Disease Epidemiologist (United Kingdom)

Dr Rainer Bliefert, Dentist (Switzerland)

Dr Michael Brandner, Dr. Med. (Medical Doctor) (Germany)

Dr Rachel Brown, MBChB, LLM (Medical Law & Ethics), MRCPsych CFMP, Consultant Psychiatrist (Medical Doctor) (United Kingdom)

Dr Roxana Bruno, PhD in Immunology, Researcher in Biochemistry, Immunology, Neuroimmunology and Genetics (Scientist) (Argentina)

Dr Elizabeth Burton, MBChB, General Medical Practitioner (Retired)(Medical Doctor) (United Kingdom)

Dr Natalia Prego Cancelo, MD, Community and Family Medicine Specialist, founder of “Médicos por la Verdad” (Doctors for the Truth) worldwide, platform of doctors in more than 17 countries (Medical Doctor) (Spain)

Professor David P. Capper, MD, Internal Medicine, Hospice & Palliative Medicine, Professor and Chair, Department of Clinical Sciences, Director of Palliative Care (Medical Doctor) (USA)

Dr Ronald S. Carlson, AB Chem/Bio, DDS, Dentist (USA)

Dr Rafael Reinoso Casado, Family and Community Medicine (Medical Doctor) (Spain)

Dr Alexandra Henrion Caude, Researcher, PhD in Molecular Biology and Genetics, Focus in Epigenetics and non-coding RNA and mitochondria, Focus on simple, durable ethical, low-cost solutions for Health and One Health, CEO of SimplissimA Research Institute, Former Director of Research at the French NIH (Retired), Member of the Circle for Innovation Galien (France), Member of the IDF Ethical Space Committee, Eisenhower Fellow from the Multination Program (Scientist) (France and Mauritius)

Dr Volker Christoffel, PhD in Biochemistry, Specialist in preclinical development (Scientist) (Germany)

Dr Vernon Coleman, MB, ChB, General Practice Principal (Retired) (Medical Doctor) (United Kingdom)

Isabella Cooper, BSc (Hons) Biochemistry, AFHEA, AMRSB, AfENDO, Doctoral Researcher, Areas of expertise: hyperinsulinaemia, disseminated intravascular coagulability, mitochondrial molecular biology and cancer metabolism (Scientist) (United Kingdom)

Dr Johan Corthouts, General Practitioner (Medical Doctor) (Belgium)

Jonathan Jay Couey, Assistant Professor of Research, Pitt School of Medicine Research Faculty, Department of Neurobiology, examining cortical and subcortical microcircuits using promotor/enhancer driven gene expression (Scientist) (USA)

Dr David Critchley, BSc, PhD, Clinical Research Scientist with more than 30 years experience, including projects in Virology and Immunology (Scientist) (United Kingdom)

Professor Barbara A Crothers, DO, Associate Professor, Pathology, Gynecologic, Breast and Cytopathology (USA)

Dr Rita Darby, General Practitioner (Medical Doctor) (Wales)

Dr. Daniel de la Torre Llorente, Biology Professor, Biotechnology-Plant Biology Department, Agronomic, Food and Biosystems Engineering School (ETSIAAB) Universidad Politécnica de Madrid (Scientist) (Spain)

Dr John Day, MD, Family Medicine (Board certified since 1990) (Medical Doctor) (USA)

Dr Hilde De Smet, General Practitioner (Medical Doctor) (Belgium)

Dr Johan Denis, General Practitioner (Medical Doctor) (Belgium)

Dr Steven Depicker, General Practitioner (Medical Doctor) (Belgium)

Dr Cindy de Villiers, MBChB, General Practitioner (Medical Doctor) (New Zealand)

Dr M. Doesburg-van Kleffens, MSc, PhD, Specialist in Laboratory Medicine (Clinical Chemistry), of Stichting Artsen Covid Collectief, an independent Dutch Collective of Medical Professionals (Scientist) (The Netherlands)

Dr Geanina Dragnea, Obstetrician-Gynecologist (Medical Doctor) (Romania)

Dr Doris Draehne, Specialist in Obstetrics and Gynaecology (Medical Doctor) (Germany)

Dr Nyjon Eccles, BSc, MBBS, MRCP, PhD, Specialist in Functional & Environmental Medicine (Medical Doctor) (United Kingdom)

Dr Karin Eisfeld, Molecular Biologist, Senior Regulatory Affairs Manager in the approval of new drugs and medical devices (Scientist) (Germany)

Dr Blanca Assumption Lario Elboj, Specialist in Ophthalmology (Medical Doctor) (Spain)

Dr Kjetil H. Elvevold, Senior Scientist, worked as Senior Scientist in a Contract Research Organization (CRO) in Norway that performed pre-clinical experiments for the pharmaceutical industry (Scientist) (Norway)

Dr Andreas Emmert, Specialist in Microbiology, Head Physician at Østfold Regional Hospital, Norway (Medical Doctor) (Norway)

Merit Enckell, Civ. Ing, PhD, Independent researcher, Structural Health Monitoring and Emerging Technologies, Formerly of KTH Royal Institute of Technology (Scientist) (Sweden)

Dr Sonia Andrés Espallardo, Psychiatrist (Medical Doctor) (Spain)

Dr Radimé Farhumand, Specialist in Anesthesia (Medical Doctor) (Germany)

Dr Thomas Faulkner, MChiro, DC, Managing Director and Chiropractor (United Kingdom)

Dr Susan Flett, Specialist in Psychiatry, Child Psychiatry and Psychotherapy (Semi-retired) (Medical Doctor) (United Kingdom)

Dr Konstantinos Fountzoulas, MD, PGDiP Orth Eng., FEBOT, FRCS (Tr & Orth), Consultant Trauma and Orthopaedic Surgeon (Medical Doctor) (England and Italy)

Dr Paul Christian Friedl, Ophthalmologist (Medical Doctor) (Austria)

Dr Carrie Ganek, MD, Adult Psychiatry (Medical Doctor) (USA)

Dr Martin E Ganek, MD, Board Certified Paediatrician (Medical Doctor) (USA)

Dr Emanuel E. Garcia, MD (University of Pennsylvania School of Medicine, 1986), Psychiatrist (Medical Doctor) (USA)

Dr Parisi Giovanni, Specialist in Ophthalmology and Sports Medicine (Medical Doctor) (Italy)

Dr Hartmut Glossmann, Professor Emeritus, Doctor of Medicine and Specialist in Pharmacology / Clinical Pharmacology, Institute for Biochemical Pharmacology, Innsbruck (Medical Doctor and Scientist) (Germany)

Amparo de Luque González, Dentist (Spain)

Dr Alexandra Efthimiadou Griva, MD, Physician, practicing natural medicine for over 40 years (Medical Doctor) (Greece)

Dr Maria-Myrto Griva, MD, Physician, with a special focus on natural medicine (Medical Doctor) (Greece)

Dr Kleanthis Grivas, MD, PhD, Neurologist — Psychiatrist, author of books and articles, writer on Totalitarian Therapeutic State (Medical Doctor) (Greece)

Dr Céline Guérin, PhD in Neurosciences, Master in Microbiology and Genetics (Scientist-Practitioner) (France)

Dr Nicholas James Guntobon, MBBCh, BAO, LRCP, SI, General Practitioner (Medical Doctor) (Malaysia) 

Dr. Olga Petrovna Guzova, Pediatrician, Dermatologist and Dermatopathologist (Medical Doctor) (Panama)

Dr Hans-Michael Hackenberg, Family Doctor and Sports Medicine Specialist (Retired) (Medical Doctor) (Germany)

Dr Roman Häussler, General Medicine (Austria)

Dr Jutta Heinrich-Nols, Doctor and Clinical Pharmacologist (Medical Doctor and Scientist) (Germany)

Julie Henrotte, Quality System Expert, 12+ years in GSK Pharma (Scientist) (Belgium)

Dr Angel Ruiz-Valdepeñas Herreros, Bachelor of Medicine, Licenciado en Medicina por la Universidad de Murcia, Specialist in Family and Community Medicine, co-founder of “Médicos por la Verdad” (Doctors for the Truth) worldwide, platform of doctors in more than 17 countries (Medical Doctor) (Spain)

Dr Birgit Hörger, Resident Doctor, Specialist in General Medicine (Medical Doctor) (Germany)

Dr Mignon Hugues, MD, General Practitioner (Medical Doctor) (Belgium)

Dr April M. Hurley, MD, Family Physician for 35 years (Medical Doctor) (USA)

William Ip, BSc. MIBMS, Former NHS Biomedical Scientist (Specialist in Microbiology), for over 30 years (Scientist) (United Kingdom)

Prof. Dr Ciro Isidoro, Doctor of Science and Medical Doctor, Full Professor of Pathology, School of Medicine, Department of Health Sciences, Università del Piemonte Orientale, Novara (Medical Doctor and Scientist) (Italy)

Dr Hervé Janecek, Veterinarian (France)

Hannah Januszczyk, Psychiatric Pharmacist (England)

Jerzy Jaskowski, MD, PhD, MS, Specialties in General Surgery, Environmental Medicine, Physics and Biophysics (Retired)(Medical Doctor and Scientist) (Poland)

Dr. Elisabeth Jenik, General Medicine, Occupational Medicine and Psychosomatic Medicine (Medical Doctor) (Austria)

Dr Alain Joseph, General Medicine Specialist (Retired) (Medical Doctor) (France)

Dr Konstantinos Kakleas, MD, MRCPCH, MSc, PhD, Paediatric Allergy Consultant, Leicester Royal Infirmary Hospital (Medical Doctor) (United Kingdom)

Dr George Katsonis, Homeopathic Doctor (Medical Doctor)(Cyprus)

Dr Hootan Kazemi, BDS Dental Surgeon, MSc(Distinc.) Clinical Biochemistry, BSc(Hons) Physiology (General Dental Practitioner) (United Kingdom)

Dr Richard Kent MB BS, Retired General Practitioner (Medical Doctor) (United Kingdom)

Dr Ingrid Kiesel, Specialist in Psychiatry, Psychotherapy and General Medicine (Medical Doctor) (Germany)

Dr Alina Kislich, General Practitioner, Graduated from the Medical University of Vienna (Medical Doctor) (Austria)

Dr Wiltrud Kling, Specialist in General Medicine (Medical Doctor) (Germany)

Dr Ewa Konik, MD, Heart Transplant Cardiologist (Medical Doctor) (USA)

Dr Doris Krien, Assistant Doctor, Günzburg District Hospital (Medical Doctor) (Germany)

Brigitte Lacroix, clinical PKPD and PBPK modeler (Pharma industry), PhD in Pharmacy (Paris XI University), PhD in Pharmacometrics (Uppsala University) (Scientist) (France, Sweden)

Dr Andreas Lang, MD (Medical Doctor) (Germany)

Dr Paul Laursen, PhD, Adjunct Professor, AUT University (Scientist) (New Zealand and Canada)

Dr Michael S Lavender, Consultant Anaesthetist (Medical Doctor) (Australia)

Dr Tess Lawrie, MBBCh, PhD, Guideline methodologist and evidence synthesis expert, Director of The Evidence-Based Medicine Consultancy Ltd, Bath UK. Honorary Researcher at the Royal United Hospital, Bath UK (Medical Doctor and Scientist) (United Kingdom)

Dr Bronia Lee, MBBCh, MRCGP, Retired General Practitioner (Medical Doctor) (United Kingdom)

Dr Katrina Lewis, MD, BSc in Immunology and Physiological Chemistry, triple Board certified ( USA) in Anesthesiology, Pain Medicine and Functional Medicine (Medical Doctor) (South Africa, USA)

Dr Derek Lohan, Consultant Radiologist, and Director, Helix Radiology (Medical doctor) (Ireland)

Dr Ricardo Arriola López, General Medicine, (Medical Doctor) (Spain)

Dr. Adele Lorigan, BSC (Chiro), Chiropractor (Australia)

Dr Antje Lueg, Specialist in Ophthalmology (Medical Doctor) (Germany)

Dr. Thomas Ly, MD, Infectologist and Paediatrician, Specialized in Tropical Medicine, Head of MedicalQM, a think tank on medical quality management and patient safety, Founder of the upcoming International Institute for Human Pathogenic Infectious Diseases “InfectCore” (Medical Doctor) (Germany and Thailand)

Dr Kulvinder S. Manik, MBChB, MA, LLM, MRCGP, GP (Medical Doctor) (England)

Dr. Rosemarie Mayr, Specialist in Psychiatry and Psychotherapeutic Medicine and Child and Adolescent Psychiatry, ÖÄK Diploma for Homeopathy (Retired) (Medical Doctor) (Germany)

Dr Nathi Mdladla, Associate Professor and Chief of ICU, Dr George Mukhari Academic Hospital and Sefako Makgatho University (Medical Doctor) (South Africa)

Dr Janet Menage, MA, MB, ChB, General Medical Practitioner (Retired) Qualified Psychological Counsellor (Medical Doctor) (United Kingdom)

Dr Niall McCrae, PhD, MSc, RMN, Mental health researcher, Psychiatric Nurse (United Kingdom)

Professor Nathalie McDonell, MD, PhD (human genetics), Professor of Molecular and Cell Biology (Medical Doctor and Scientist) (France)

Dr Ciaran Montague, MVB, MRCVS, Royal College of Veterinary Surgeons certified veterinary dermatologist with 25 years general and referral practice (Veterinarian) (N. Ireland)

Dr Alistair J Montgomery, MB.ChB., MRCGP, DRCOG, NHS General Practitioner (Retired) (Medical Doctor) (UK)

Dr Sabine de Monvallier, General Practitioner (Medical Doctor) (France)

Dr Ines Mörbitz, Specialist in General Medicine (Medical Doctor) (Germany)

Dr Amir Mortasawi, Physician and author (Germany)

Dr Jens Münch, Neurologist, Psychoanalyst and Specialist in Psychosomatic Medicine and Trauma (Medical Doctor) (France)

Dr. Graeme Munro-Hall, BDS, Dentist (retired), pioneered the use of glutathione with vitamin C, awarded a Fellowship of the International Academy of Oral Medicine and Toxicology in 1996 (Dentist) (United Kingdom)

Dr Souha Nasreddine, MD, Ob/Gyn, Graduated from the Free University of Brussels Belgium, Holistic Gynecology (Lebanon)

Dr Meryl Nass, MD, BS Biology (M.I.T.), Specialist in Internal Medicine, with a focus on fibromyalgia, chronic fatigue syndrome, Gulf War illnesses, and anthrax vaccine injuries. First person to demonstrate that an epidemic resulted from biowarfare. Helped lead a coalition to fight anthrax vaccine mandates and revoke the vaccine license (Medical Doctor) (USA)

Dr Anthousa Nicolaidou, MD, General Practitioner and Holistic Doctor (Medical Doctor) (Cyprus)

Akhmetzhanova Tamara Nikolaevna, Therapist and Cardiologist, the Republican Medical Genetic Center, Ufa (Medical Doctor) (Russia)

Dr Terezia Novotna, General Practitioner, Emergency Doctor, and Anesthesiologist in Training (Medical Doctor) (Austria)

Ole C G Olesen, Double specialist in General Surgery, as well as Orthopedic Surgery and Trauma (Medical Doctor) (Denmark, Norway, Sweden, and United Kingdom)

Dr Carlos Muñoz-Caravaca Ortega, Graduate in Surgery, Specialist in Emergency Medicine (Medical Doctor) (Spain)

Dr Fatma Özguler, Specialist in Internal Medicine, General Medicine and Emergency Medicine (Medical Doctor) (Germany)

Dr Waltraud Parta-Kehry, Biologist and Doctor for Gynaecology and Reproductive Medicine (Medical Doctor) (Germany)

Dr Arun Kumar Patel, MBBS, MPH, MRCPH, FFPH, Medical Public Health Specialist (Retired), NHS (Medical Doctor) (United Kingdom)

Dr E. Peeters, MD, Internal Medicine Specialist, Endocrinology, of Stichting Artsen Covid Collectief, an independent Dutch Collective of Medical Professionals (Medical Doctor) (The Netherlands)

Dr Berber Pieksma, General Practitioner (Medical Doctor) (The Netherlands)

Dr. Cristina Pinho, MD, Gastroenterologist (Medical Doctor) (Portugal)

Dr Hélène Potrich, General Practitioner (Medical Doctor) (France)

Panagiotis Papaspyrou, Specialist in Orthopedics (Germany)

Dr Fabio Quirici, Swiss Medical Association (Medical Doctor) (Switzerland)

Professor Denis Rancourt, PhD, Researcher, Ontario Civil Liberties Association, Member scientist, PANDA (Pandemics Data & Analysis), Retired former Full Professor of Physics, University of Ottawa, with expertise in environmental nanoparticles, molecular science, molecular dynamics, statistical analysis methods and mathematical and epidemiological modeling (Scientist) (Canada)’

Dr Sabine Rauch, General Practitioner, Specialist in General Medicine (Medical Doctor) (Germany)

Dr Rafael Reinoso, Family and Community Medicine (Medical Doctor) (Spain)

Dr Nicola Reiser, Anaesthetist, and Intensive Care Physician, Senior Physician at the University Clinic UMEÅ (Medical Doctor) (Sweden)

Claudia Riempp, Psychologist and psychotherapist, expert in health education (Germany)

Dr Tred J Rissacher, DC, Chiropractor specialising in obesity and diabetes (USA)

Pablo Enrique Palomo Robles, Pharmaceutical Chemist, Ministry of Public Health and Social Assistance (Scientist) (Guatemala)

Rhys Rogers, BSc, Physiotherapy, 12 years experience as a frontline Physiotherapist (United Kingdom)

Dr Tamara Roycroft, BMBS, BSc (Hons) Nutrition, AIT RCGP, Doctor, Nutritionist and Former Research Scientist/Research Physician in the pharmaceutical industry, and Co-Investigator on vaccine trials (Medical Doctor and Scientist) (United Kingdom)

Professor Simon Ruijsenaars, Professor in Mathematical Physics, School of Mathematics, University of Leeds (Scientist) (United Kingdom)

Dr Claudio Sacilotto, MD, Otolaryngologist and Audiologist, former Professor at the University of Udine and former Doctor at the Udine University Hospital, former Professor at the Music Conservatory of Udine (Medical Doctor) (Italy)

Dr Sam Saidi, MB, ChB, BSc, FRCOG, PhD, University of Sydney (Medical Doctor and Scientist) (Australia)

Dr. Vanessa Schmidt-Krüger, Cell Biologist with over 20-year experience in molecular medicine, Max Delbrück Center for Molecular Medicine (Scientist) (Germany)

Dr Claudia Schoene, Veterinarian with specialisation in Veterinary Epidemiology and Tropical Veterinary Medicine, Animal Health Management and Wildlife management, Formerly Scientific Researcher at the Institute for Epidemiology of the German Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, and the Information Centre for Biological Security of the Robert-Koch Institute (Veterinarian and Scientist) (Germany)

Dr Eva-Maria Schottdorf, MD, MSc, Master of Science in Drug Research and Management, Emergency Physician, Board Certified Specialist in Radiation Oncology (Medical Doctor) (Germany)

Dr Ullrich Schubert, (Medical Doctor) (Germany)

Dr Pamela Shervanick, DO, Medical doctor and Doctor of Osteopathic Medicine, with specialization in Psychiatry (Medical Doctor) (USA)

Dr Guido Spanoghe, Gastroenterologist (Medical Doctor) (Belgium)

Dr Dietmar Spengler, Paediatrician and Neonatologist (Medical Doctor) (Germany)

Dr. Jutta Steinacker-Palden, General Practitioner (Medical Doctor) (Austria)

Dr Paul Steven Spradbery, Forensic and Research Biologist, Foundation for Science and Technology, Lisbon, Intertek Life Sciences, London (Scientist) (United Kingdom)

Dr Duncan Syme, MBBS, FRACGP, Dip Prac Derm University of Cardiff, Graduate Monash University 1987, General Practitioner (Medical Doctor) (Australia)

Dr Carol Taccetta, MD, FCAP (Fellow of the College of American Pathologists), Pharmaceutical Physician for over 25 years, specializing in drug safety (Medical Doctor) (USA)

Dr Noel Thomas, MA, MB, ChB, DCH, DObsRCOG, DTM&H, MFHom. Semi-retired NHS GP and homeopath (Medical Doctor) (United Kingdom)

Dr Corinne Tilloy, General Practitioner, (Medical Doctor) (France)

Dr Gilbert Tominez, General Practitioner (Retired) (Medical Doctor) (France)

Dr M. Tóth, MD, Psychiatrist, of Stichting Artsen Covid Collectief, an independent Dutch Collective of Medical Professionals (Medical Doctor) (The Netherlands)

Dr Julio Trindade, Masters in Epidemiology, Doctor of Veterinary Medicine, Masters in Strategy (Veterinarian & Epidemiologist) (Uruguay)

Dr Georgy Urushadze, Naturopathic Doctor, Paediatrician (Pirogov Russian National Medical University), Emergency Doctor, Physiotherapist, Researcher (Russia)

Dr Francisco J. Llull Vera, Dental Medicine Doctor, graduated from the Dental Medicine School (University of Puerto Rico, Puerto Rico), Postdoctoral Studies in Infectious Diseases (Harvard University, MA), Postdoctoral Studies in Dental Implantology and Oral Surgery (NYU Dental Medicine School, NY), Former President Puerto Rico College of Surgeons Dentists, South Region (Dentist) (Puerto Rico)

Dr H. Visser, MD, Internal Medicine Specialist, and Infectologist, of Stichting Artsen Covid Collectief, an independent Dutch Collective of Medical Professionals (Medical Doctor) (The Netherlands)

Dr Jasmina Vucic-Peev, PhD, studied in Freiburg, Germany, training in Psychiatry in Switzerland (Medical Doctor) (Germany, Switzerland, Portugal)

Dr William H. Warrick III, MD, Family Practice Doctor (Retired) (Medical Doctor) (USA)

Dr Jo Waller, UK State registered Biomedical Scientist since 1990 (Scientist) (United Kingdom)

Dr Maja Waibel, Dermatologist with specialty in Melanoma prevention (Medical Doctor) (Germany)

Dr Gerard A Waters, Mb, Bch, BAO, MICGP, General Practitioner (Medical Doctor) (Ireland)

Dr Craig M. Wax, DO, Family Physician, Founder of Independent Physicians for Patient Independence, Host of Your Health Matters (Medical Doctor) (USA)

Dr Markus Wegscheider, General Practitioner (Austrla)

Dr Ronald Weikl, Gynecologist and General Practitioner (Medical Doctor) (Germany)

Dr Helen Westwood MBChB (Hons), MRCGP, DCH, DRCOG, GP (Medical Doctor) (United Kingdom)

Dr R Matison White, MD, Family Practice Physician of 49 years (Medical Doctor) (USA)

Dr Madhu Wickremaratchi, MBChB, MRCP, Acute and General Medicine (United Kingdom)

Dr Anna Maria Wiedemann, General Practitioner, Specialist in General Medicine (Medical Doctor) (Sweden and Germany)

Dr Clive Wilder-Smith, FRCP, AGAF, MD, Consultant Gastroenterologist, Director of Research (Medical Doctor) (Switzerland)

Thomas Robin Wilks, MA, BSc(Hons) FHEA, CPhys, MInstP, University Science Lecturer, Math, Mathematical Modelling and Physics, Open University (Scientist) (United Kingdom)

Dr Christopher Wood, MBBS, Retired General Practitioner (Medical Doctor) (United Kingdom)

Dr Olga Sergeevna Yakimanskaya, General Practitioner, Polyclinic Physician (Medical doctor) (Russia)

Dr Reinhild Zenklusen, MD, Pathologist and Cytopathologist (Medical Doctor) (Switzerland)

Dr. med. Christian Zürcher, Management Medic Integral GmbH, Integrative Pain Therapy – Pain-Reset plus, Pain Specialist SGSS, FA Neural Therapy SANTH, Hirudotherapist EMR, General Internal Medicine FMH (Germany)

Dr. Giancarlo Majorano, Surgeon, ASL Na 1 Medical Director, Specialist in Child Psychiatry and Neuropsychiatry (Italy)

Dr. G. Karl Snaebjornsson MD, Specialist in Family Medicine, practice in Sweden, Iceland and Norway (consulting work) (Iceland)

Dr. Claus Hancke MD FACAM, Specialist in General medicine (Denmark)

Dr. Andrea Málková M.D., General Practitioner, Integrative Medicine (Czech)

Christina Del Prete, Pharmacist & Complementary Therapist Consultant / Referent of mineral salts sec. Dr. Schüssler (GBA Austria), Micronutrition Consultant (FOM & Mikronährstoffberaterin, AMM (D)) (Switzerland)

DR. Erika Drewes, Functional/Interactive HPCSA Registered Family Physician (South Africa)

Dr. Priyanka Bandara, PhD (Biochemistry & Molecular Genetics), Independent Researcher in Environmental Health, formerly Academic Clinical/Basic Researcher at University of Sydney and UNSW Medicine as well as Westmead and RPA Hospitals, Sydney, NSW (Australia)

Marwan Wahba, RPh, MBA, MSIME (c) (USA)

Dr. Helene Reinhardt, Medical Doctor, Psychiatrist (France)

DR. Anna Ansel, MD, Licensed in Switzerland and Germany (on the way to get a medical license in Florida/USA), Practiced Psychiatry and Psychotherapy in Switzerland (USA)

Dr. Lavinia Ansel, Specialist in Anesthesiology (RETIRED), Licensed in Germany

Dr. Vit Kopecky, MUDr (Charles University, Prague), General Practitioner, Acute Care (Finland)

Dr. Etienne P LeBel, PhD, Independent Consultant (Meta-scientist), Founder & Lead of Curate Science (Canada)

Dr. Nina Pierpont, MD from Johns Hopkins 1991, PhD from Princeton 1985 in Population Biology( Ecology, Evolution, & Behavior), BA from Yale 1977, Board-certified in Pediatrics, in Private Practice of Behavioral Medicine, Author of Wind Turbine Syndrome, A Report on a Natural Experiment, 2009 (USA)

Dr. Mario Volker Fringes, Medical Doctor, Internal Medicine (self-employed) (Germany)

Dr. Dominik Sakry, PhD in Neuroscience (Scientist) (Germany)

Dr. Kurt Lindekilde, MD, private practice, psychotherapy (Denmark)

Dr. Sabrina Moerkl, Doctor in Medical Science, Psychiatrist (Austria)

Dr. Margrit Järmann, Medical Doctor, Specialist in General Internal Medicine (Switzerland)

Dr. Claudia Chaufan, MD and PhD, Associate Professor, Health Policy & Global Health, York University (Canada)

Signatures of Colleagues in Allied Disciplines relating to Ethics, Health and Human Rights

Reece Francis Allawatt, Registered Nurse, Specialty in Psychiatry and Mental Health (USA)

Sue Cook, BSc (Hons) Lic LCCH, Neurodevelopment Specialist (United Kingdom)

Joseph Dassas, LLB, LLM, LPC, Solicitor and Advocate (Greece, Israel, United Kingdom)

Professor Peter Gichure, Associate Professor of Theology and Peace Studies, Catholic University of Eastern Africa, Director of Graduate Studies, with special interest in ethics (Kenya)

Nuria Iturralde, LL.M, MBA, Human Rights Lawyer (Luxembourg)

Dr Chris Lavers, BSc Hons (Exon), PhD, FHEA, M Inst P, C Phys, C Sci, ILTM, RUT, PGCE(LTHE), Academic Programme Manager DipHE in Marine Studies, Subject Matter Expert (Sensors), Dartmouth Centre for Sea Power and Strategy, Plymouth University at Britannia Royal Naval College, Visiting Research Fellow, Changing Character of War Centre, Pembroke, Oxford (UK)

Dr. Reinhard Lindner, MBA, Economist (Austria)

Shabnam Palesa Mohamed, Journalist, Activist and Mediator (South Africa)

John O’Sullivan, CEO of Principia Scientific International, an independent international scientific body defending the traditional scientific method, incorporated for charitable purposes as a Community Interest Company (United Kingdom)

Matthieu Smyth, Anthropologist, University of Strasbourg (France)

Dr Violeta Sotirova, MPhil, PhD, Lecturer in English (United Kingdom)

United People’s Front (EPAM) Health Committee, Independent political party (Greece)

Konstantinos Nik. Tsovolas, Attorney at Law, Expertise in Criminal Law, Practicing in Athens (Greece)

Eric R. Hirtle, Sterile Processing Technician (USA)

Joao Manuel Alvarez MAOM L.Ac, Traditional Chinese Medicine, Medical Research (USA)

France Quirin, Registered Osteopath, Working with clients ME/CFS (UK)


Dr. Michael Yeadon shared this resource on Steve Kirsch's Substack. Please click this link to see the original page: https://c19early.com/


Treatment
Improvement
  (early)
Studies
  (early)
Sotrovimab89%1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paxlovid83%2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Budesonide82%1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remdesivir76%2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bamlaniv../e..73%7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hydroxychlor..64%35
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fluvoxamine64%3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ivermectin63%32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zinc61%4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Casirivimab/i..55%10
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Molnupiravir55%5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Favipiravir43%7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vitamin C43%3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Early treatments approved by >2 countries. 68 countries have officially approved treatments. Details.
Recent studies (see the individual treatment pages for all studies):

Feb 15
MetaShah et al., QJM: An International Journal of Medicine, doi:10.1093/qjmed/hcac040 (Peer Reviewed) (meta analysis)
death, ↓52.1%, p<0.0001
Does vitamin D supplementation reduce COVID-19 severity? - a systematic review
Details   Meta-analysis of seven systematic reviews showing that vitamin D supplementation reduces the risk of COVID-19 mortality, ventilation, and ICU admission. Authors note that oral and IV supplements were well tolerated, safe, and effective.
Feb 15
LateAl Mutair et al., Journal of Infection and Public Health, doi:10.1016/j.jiph.2022.01.013 (Peer Reviewed)
death, ↓7.0%, p=0.49
Overview of Clinical Outcome and Therapeutic Effectiveness of Favipiravir in Patients with COVID-19 Admitted to Intensive Care Unit, Riyadh, Saudi Arabia
Details   Retrospective 269 favipiravir ICU patients in Saudi Arabia and 269 matched controls receiving different treatments, showing no significant difference.
Feb 15
EarlyLowe et al., medRxiv, doi:10.1101/2022.02.11.22270775 (Preprint)
ICU, ↑196.3%, p=1.00
Favipiravir, lopinavir-ritonavir or combination therapy (FLARE): a randomised, double blind, 2x2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
Details   240 patient RCT comparing favipiravir, favipiravir + LPV/r, LPV/r, and placebo, showing improved viral clearance with favipiravir. Efficacy was lower in the combined favipiravir + LPV/r arm, where plasma levels of favipiravir were lower. ..
Feb 13
LateBeaumont et al., Infectious Diseases Now, doi:10.1016/j.idnow.2022.02.001 (Peer Reviewed)
death/int., ↓14.1%, p=0.55
Factors associated with hospital admission and adverse outcome for COVID-19: role of social factors and medical care
Details   Retrospective 296 hospitalized patients in France, showing no significant difference with HCQ treatment.
Feb 12
EarlyLilly (Preprint)
death, ↑150.8%, p=1.00
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness
Details   RCT with 127 bamlanivimab, etesevimab, and bebtelovimab patients, 125 bebtelovimab patients, and 128 control patients, showing no significant differences in hospitalization and mortality. Viral clearance was improved although not statisti..
Feb 10
EarlyBrennan et al., Gut, doi:10.1136/gutjnl-2022-326952 (Peer Reviewed)
no recov., ↓48.1%, p=0.23
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial
Details   Small RCT with 27 famotidine and 28 placebo patients, showing improved recovery with treatment. Recovery was faster with treatment for 14 of 16 symptoms. There was no mortality or hospitalization. NCT04724720.
Feb 9
EarlyFriedland et al., Australian Journal of Otolaryngology, doi:10.21037/ajo-21-40 (Peer Reviewed)In vivo (human) and in vitro inactivation of SARS-CoV-2 with 0.5% povidone-iodine nasal spray
Details   Small study of povidone-iodine nasal spray with 14 patients, showing rapid reduction in viral load for the 6 patients that had culturable virus at baseline. All patients remained PCR+ despite no culturable virus detected for 3 of 6 patien..
Feb 9
EarlyDale et al., Journal of the American Geriatrics Society, doi:10.1111/jgs.17705 (Peer Reviewed)
death, ↓89.2%, p=0.010
Clinical Outcomes of Monoclonal Antibody Therapy During a COVID ‐19 Outbreak in a Skilled Nursing Facility‐Arizona, 2021
Details   Retrospective 75 COVID+ patients in a skilled nursing facility in the USA, 56 treated within a median of 2 days from symptom onset with bamlanivimab, showing significantly lower mortality with treatment.
Feb 9
AnimalMiorin et al., bioRxiv, doi:10.1101/2022.02.08.479634 (Preprint)
animal study
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters
Details   In Vitro study showing that nitazoxanide inhibits SARS-CoV-2 in H9, iAT2, Vero E6, Vero TMPRSS2, and Ace2-A549 cells. Syrian hamster study showing improvements in SARS-CoV-2 related weight loss, inflammation, viral load, and lung synctia..
Feb 8
LevelsIvanova et al., Journal of Trace Elements in Medicine and Biology, doi:10.1016/j.jtemb.2022.126944 (Peer Reviewed)Evaluation of zinc, copper, and Cu:Zn ratio in serum, and their implications in the course of COVID-19
Details   Retrospective 75 COVID-19 hospitalized patients and 68 healthy controls in Bulgaria, showing mortality associated with lower zinc levels.
Feb 5
LateBishop et al., medRxiv, doi:10.1101/2022.01.31.22270036 (Preprint)
no recov., ↓33.7%, p=0.56
Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19
Details   Small RCT with low-risk patients in Florida, USA, showing no significant differences in overall recovery. Minimal details on outcomes are provided in the preprint. Authors note significantly faster resolution of respiratory symptoms when ..
Feb 5
LateSánchez-Rico et al., Journal of Travel Medicine, doi:10.1093/jtm/taab195 (Peer Reviewed)
death, ↓19.0%, p=0.15
Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study
Details   Retrospective database analysis in France with 272 patients treated with melatonin, showing 19% lower mortality after adjustments, without statistical significance. Risk was lower for higher dosage (not statistically significant). Age was..
Feb 4
LateFowotade et al., medRxiv, doi:10.1101/2022.02.03.22270152 (Preprint)
no recov., ↑11.4%, p=0.72
Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19
Details   Small RCT in Nigeria with 31 nitazoxanide and atazanavir/ritonavir patients, and 26 control patients, showing no significant differences with treatment. 4 treatment group patients discontinued treatment due to the size of the tablets. Tim..
Feb 3
ReviewSwanstrom et al., Science, doi:10.1126/science.abn0048 (Review) (Peer Reviewed)
review
Lethal mutagenesis as an antiviral strategy
Details   Review of the unknown long-term cancer, reproductive, and escape variant creation risks of molnupiravir. For more discussion see [1, 2, 3].
Feb 3
LateAlbanghali et al., Journal of Infection and Public Health, doi:10.1016/j.jiph.2022.02.001 (Peer Reviewed)
death, ↑34.6%, p=0.46
Clinical Characteristics and Treatment Outcomes of Mild to Moderate Covid-19 Patients in Saudi Arabia: A Single Centre Study
Details   Retrospective 811 hospitalized COVID+ patients in Saudi Arabia, showing higher mortality with HCQ treatment in unadjusted results subject to confounding by indication.
Feb 2
LatePourdowlat et al., Phytotherapy Research, doi:10.1002/ptr.7319 (Peer Reviewed)
hosp., ↓72.8%, p=0.004
Efficacy and safety of colchicine treatment in patients with COVID-19: A prospective, multicenter, randomized clinical trial
Details   RCT 202 patients in Iran, 102 treated with colchicine, showing lower hospitalization and improved clinical outcomes with treatment.
Feb 2
EarlyManomaipiboon et al., Research Square, doi:10.21203/rs.3.rs-1290999/v1 (Preprint)
no recov., ↓43.5%, p=0.26
Efficacy and safety of ivermectin in the treatment of mild-to-moderate COVID-19 infection: A randomized, double blind, placebo, controlled trial
Details   Small RCT with 72 low-risk patients in Thailand, showing improved recovery with ivermectin, without statistical significance. All patients recovered and there was no escalation of care in either group. There were no adverse events.
Feb 1
LateTuran et al., The Brazilian Journal of Infectious Diseases, doi:10.1016/j.bjid.2022.102328 (Peer Reviewed)
hosp., ↓79.4%, p=0.001
The effect of favipiravir versus hydroxychloroquine on clinical and laboratory findings in COVID-19 in healthcare workers
Details   Retrospective 237 low-risk healthcare workers in Turkey, 123 treated with favipiravir and 114 treated with HCQ, showing lower hospitalization and faster viral clearance with favipiravir, and similar improvement. This study is subject to s..
Jan 31
EarlyShopen et al., medRxiv, doi:10.1101/2022.01.29.22270090 (Preprint)
severe case, ↑45.6%, p=0.26
Doubtful Clinical Benefit of Casirivimab-Imdevimab Treatment for Disease Severity Outcome of High-Risk Patients with SARS-CoV-2 Delta Variant Infection
Details   Retrospective 359 COVID+ patients in Israel, 116 treated with casirivimab/imdevimab, showing no significant difference with treatment in multivariable analysis.
Jan 31
ReviewTan et al., Life Sciences, doi:10.1016/j.lfs.2022.120368 (Review) (Peer Reviewed)
review
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
Details   Review of the mechanisms of action and clinical evidence supporting the use of melatonin for severe COVID-19.
Jan 31
In VitroKowa News Release (News) (In Vitro)
news
Antiviral effect of ivermectin confirmed for omicron
Details   Kowa reports that ivermectin is effective for omicron in In Vitro research.
Jan 31
PrEPSubramanian et al., The American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqac027 (Peer Reviewed)
death, ↓27.3%, p=0.12
Vitamin D, D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patients
Details   Retrospective 427 hospitalized COVID-19 patients in the United Kingdom, showing lower mortality with vitamin D supplementation (p=0.12), and higher mortality with both low and high vitamin D levels compared to a reference range of 50-74 n..
Jan 29
PrEPMohajeri et al., Mediterranean Journal of Nutrition and Metabolism, doi:10.3233/MNM-211521 (Peer Reviewed)The difference in the dietary inflammatory index, functional food, and antioxidants intake between COVID -19 patients and healthy persons
Details   Retrospective dietary survey analysis of 500 COVID-19 patients and 500 healthy matched controls in Iran, showing that COVID-19 patients had lower daily consumption of vitamin C, vitamin D, vitamin E, zinc, and selenium. IR.ARUMS.REC.1400...
Jan 28
LateKartika et al., ICE on IMERI, 2021 (Preprint)
hosp. time, ↓41.0%, p=0.048
Curcumin as adjuvant Therapy in Mild - Moderate Covid 19
Details   Retrospective 246 hospitalized patients in Indonesia, 136 treated with curcumin, showing shorter hospitalization time with treatment. All patients received vitamin C, D, and zinc.
Jan 27
EarlyDelasobera et al., Infectious Diseases in Clinical Practice, doi:10.1097/IPC.0000000000001109 (Peer Reviewed)
death, ↑119.4%, p=0.64
Impact of Rapidly Deployed COVID-19 Monoclonal Antibody Infusion Clinics on Rate of Hospitalization
Details   Retrospective 438 patients in the USA, 253 treated with bamlanivimab, showing significantly lower hospitalization with treatment.
Jan 27
LatePriest et al., Infectious Diseases in Clinical Practice, doi:10.1097/IPC.0000000000001130 (Peer Reviewed)
death, 0.0%, p=1.00
Bamlanivimab for the Prevention of Hospitalizations and Emergency Department Visits in SARS-CoV-2–Positive Patients in a Regional Health Care System
Details   Retrospective 379 bamlanivimab patients and 379 matched controls in the USA, showing no significant differences with treatment.
Jan 27
LevelsSchmitt et al., Journal of Medical Virology, doi:10.1002/jmv.27606 (Peer Reviewed)Oxidative stress status and vitamin D levels of asymptomatic to mild symptomatic COVID-19 infections during the third trimester of pregnancy: A retrospective study in Metz, France
Details   Retrospective 15 COVID+ pregnant women and 20 healthy controls in France, showing that all COVID+ patients were vitamin D deficient, and vitamin D levels were significantly lower in symptomatic patients compared to controls or asymptomati..
Jan 27
LateIzquierdo et al., Science Progress, doi:10.1177/00368504221074574 (Peer Reviewed)
death, ↓25.6%, p=0.0007
Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19
Details   Retrospective 19,208 COVID+ hospitalized patients in Spain, 2,071 treated with high dose NAC, showing lower mortality with treatment. In multivariable analysis, authors adjust for corticosteroids, but do not adjust for HCQ use which was a..
Jan 25
In SilicoKumar Yadalam et al., Saudi Journal of Biological Sciences, doi:10.1016/j.sjbs.2022.01.049 (Peer Reviewed)
In Silico
Assessing the therapeutic potential of angomelatine, ramelteon, and melatonin against SARS-Cov-2
Details   In Silico study of melatonin, angomelatine, and ramelteon for SARS-CoV-2, predicting significant SARS-CoV-2 RBD and ACE2 binding with all three.
Jan 25
PrEP, PEPGarcia-Albeniz et al., medRxiv, doi:10.1101/2020.09.29.20203869 (Preprint) (meta analysis)
cases, ↓28.0%, p=0.004
Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19
Details   Systematic review and meta-analysis of HCQ prophylaxis RCTs showing a statistically significant reduction in cases for pre-exposure prophylaxis. For PEP trials there were very long treatment delays - in one trial about a third of partici..
Jan 24
PrEPKaronova et al., Nutrients, doi:10.3390/nu14030505 (Peer Reviewed)
symp. case, ↓94.6%, p=0.002
Vitamin D Intake May Reduce SARS-CoV-2 Infection Morbidity in Health Care Workers
Details   Small RCT in Russia with 45 high dose vitamin D patients (50,000IU/wk for 2 wks followed by 5,000IU/day) and 46 low dose patients (2,000IU/day), showing lower cases and lower symptomatic cases with high dose treatment.
Jan 24
LevelsSaponaro et al., Frontiers in Immunology, doi:10.3389/fimmu.2021.745713 (Peer Reviewed)
ARDS, ↓36.5%, p=0.43
Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?
Details   Retrospective 93 COVID-19 pneumonia patients in Italy, showing low vitamin D levels associated with severe ARDS, and significantly lower vitamin D levels for non-survivors.
Jan 24
AnimalTatham et al., bioRxiv, doi:10.1101/2022.01.23.477397 (Preprint)
animal study
Lack of Ronapreve (REGN-CoV; casirivimab and imdevimab) virological efficacy against the SARS-CoV 2 Omicron variant (B.1.1.529) in K18-hACE2 mice
Details   K18-hACE2 mouse study showing that casirivimab/imdevimab was not effective for omicron at doses 2x higher than those effective for previous variants.
Jan 24
Earlyde Jesús Ascencio-Montiel et al., Archives of Medical Research, doi:10.1016/j.arcmed.2022.01.002 (Peer Reviewed)
death/hosp., ↓59.0%, p<0.0001
A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19
Details   Retrospective 28,048 COVID+ patients in Mexico, 7,898 receiving a treatment kit including low dose ivermectin, AZ, aspirin, and acetaminophen, shower lower mortality/hospitalization for those receiving the kit. Delivery of the treatment k..
Jan 23
PrEPErden et al., Bratislava Medical Journal, doi:10.4149/BLL_2022_018 (Peer Reviewed)
death, ↑150.0%, p=1.00
COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study
Details   Retrospective 9 COVID-19 patients with antiphospholipid syndrome in Turkey, showing no significant differences based on existing HCQ treatment.
Jan 23
In VitroLiu et al., bioRxiv, doi:10.1101/2022.01.20.477147 (Preprint) (In Vitro)
In Vitro
SARS-CoV-2 Viral Genes Compromise Survival and Functions of Human Pluripotent Stem Cell-derived Cardiomyocytes via Reducing Cellular ATP Level
Details   In Vitro study showing that ivermectin and meclizine may be protective for heart muscle damage due to SARS-CoV-2.
Jan 22
LevelsPVSN et al., Biological Trace Element Research, doi:10.1007/s12011-022-03124-7 (Peer Reviewed)Comparative Analysis of Serum Zinc, Copper and Magnesium Level and Their Relations in Association with Severity and Mortality in SARS-CoV-2 Patients
Details   Analysis of 150 COVID+ hospitalized patients in India, showing lower zinc levels associated with higher severity.
Jan 22
LevelsEkemen Keleş et al., European Journal of Pediatrics, doi:10.1007/s00431-021-04348-w (Peer Reviewed)
hosp., ↓75.3%, p=0.01
Serum zinc levels in pediatric patients with COVID-19
Details   Prospective study of 100 COVID+ pediatric patients in Turkey, showing significantly increased risk of hospitalization for patients with zinc deficiency.
Jan 22
LevelsJuraj et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2022.01.044 (Peer Reviewed)
death, ↓19.0%, p=0.05
COVID-19 pneumonia patients with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
Details   Retrospective 357 COVID-19 pneumonia patients in Slovakia, showing higher mortality with vitamin D deficiency (<12ng/mL). All patients received vitamin D supplementation in hospital. In multivariable linear regression, vitamin D levels we..
Jan 21
In VitroGoc et al., European Journal of Microbiology and Immunology, doi:10.1556/1886.2021.00022 (Peer Reviewed) (In Vitro)
In Vitro
Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants
Details   In Vitro study testing combinations of plant extracts and micronutrients with several variants of SARS-CoV-2. A combination of vitamin C, N-acetylcysteine, curcumin, quercetin, resveratrol, theaflavin, naringenin, baicalin, and broccoli e..
Jan 20
In SilicoParvez et al., arXiv:2201.08176 [q-bio.OT] (Peer Reviewed)
In Silico
Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity and possible therapeutics
Details   In Silico analysis of the omicron variant and 10 treatments reported effective for previous variants, predicting that all will be effective for omicron, with ivermectin showing the best results.
Jan 20
PrEPNguyen et al., Science Advances, doi:10.1126/sciadv.abi6110 (preprint 3/10/2021) (Peer Reviewed)
cases, ↓49.6%, p=0.006
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses
Details   Retrospective 1,212 patients in the USA with a history of seizure-related conditions, showing patients treated with CBD100 had significantly lower incidence of COVID-19 cases compared to a matched control group. In Vitro study showing CB..
Jan 18
PrEPUsman et al., Journal of Thrombosis and Thrombolysis, doi:10.1007/s11239-022-02631-7 (Peer Reviewed)
death, ↓59.8%, p=0.21
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
Details   Retrospective 75 diabetes patients, 34 on metformin, showing improved clinical outcomes with treatment, without statistical significance.
Jan 18
LateZubair et al., Monaldi Archives for Chest Disease, doi:10.4081/monaldi.2022.2062 (Peer Reviewed)
death, ↑8.9%, p=1.00
The effect of ivermectin on non-severe and severe COVID-19 disease and gender-based difference of its effectiveness
Details   Retrospective 188 hospitalized patients in Pakistan, 90 treated with ivermectin, showing no significant differences with treatment. The ivermectin group had more severe disease (66% vs 58%, with 6x higher risk for severe disease patients)..
Jan 17
LateAsadirad et al., Phytotherapy Research, doi:10.1002/ptr.7375 (Peer Reviewed)
death, ↓25.9%, p=0.74
Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial
Details   RCT 60 hospitalized patients in Iran, 30 treated with nano-curcumin, showing significant improvements in inflammatory cytokines, and improvements in clinical outcomes without statistical significance. 240 mg/day nano-curcumin for 7 days.
We aim to cover the most promising early treatments for COVID-19. We use pre-specified effect extraction criteria that prioritizes more serious outcomes, for details see methods. For specific outcomes and different treatment stages see the individual pages. Not all treatments are covered here, effectiveness has been reported for many other treatments in studies. Of the 1,447 studies, 962 present results comparing with a control group, 856 are treatment studies, and 106 analyze outcomes based on serum levels. There are 21 animal studies, 43 in silico studies, 87 in vitro studies, and 80 meta analyses.

Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.



The Ingredients of the mRNA Vaccines Are Much Worse Than Any of us Imagined.








No comments:

Post a Comment

Note: Only a member of this blog may post a comment.